Dyadic International Inc. (DYAI) vs Seres Therapeutics, Inc. (MCRB)

Dyadic International Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Dyadic International Inc. and Seres Therapeutics, Inc. are of similar size ($14.4M and $14.0M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −98.3%. Dyadic International Inc. has the higher net margin (−226.9% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 16 metrics below, Dyadic International Inc. leads on 12 and Seres Therapeutics, Inc. on 4.

Valuation

Metric DYAI MCRB Biotechnology median
P/E n/m n/m 11.36
P/S 3.97 6.67 9.12
P/B n/m 0.66 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 4.09 46.65 8.56
Earnings yield (65.63%) (352.22%) (34.18%)
Free cash flow yield (58.32%) (449.41%) (23.62%)

Profitability

Metric DYAI MCRB Biotechnology median
Gross margin 17.85% 100.00% 67.24%
Operating margin (237.12%) (3,656.89%) 0.00%
Net margin (226.87%) (2,209.55%) 0.00%
Free cash flow margin (227.93%) (2,997.74%) 0.00%
Return on equity (47,310.78%) (144.35%) (50.28%)
Return on assets (71.43%) (44.85%) (45.89%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric DYAI MCRB Biotechnology median
Revenue growth (TTM) (7.64%) (98.33%) 6.96%
EPS growth (last fiscal year) (15.00%) 0.00% 29.86%
Revenue growth, 5-year CAGR 14.04% (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.69 1.65 4.72
Net debt to EBITDA 0.49 0.51 1.01

Dividend

Metric DYAI MCRB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric DYAI MCRB Biotechnology median
Market cap 14.02m 14.37m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack